ask="12.77"
ask_size="500"
average_daily_volume="2137860"
bid="10.77"
bid_size="100"
book_value="-0.09"
change="+0.09"
change_from_200_day_moving_average="0.92"
change_from_50_day_moving_average="0.35"
change_from_52_week_high="-2.70"
change_From_52_week_low="4.72"
change_in_percent="+0.78%"
close="11.68"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.56"
ebitda="-52.95M"
eps_estimate_current_year="-0.87"
eps_estimate_next_quarter="-0.24"
eps_estimate_next_year="-0.86"
ex_dividend_date="N/A"
float_shares="94923000"
high="11.81"
high_52_weeks="14.38"
last_trade_date="1/24/2017"
last_trade_price="11.68"
last_trade_size="100756"
last_trade_time="4:00pm"
low="11.14"
low_52_weeks="6.96"
market_capitalization="1.50B"
moving_average_200_day="10.76"
moving_average_50_day="11.33"
name="Halozyme Therapeutics
Inc."
notes="N/A"
one_year_target_price="14.84"
open="11.64"
pe_ratio="N/A"
peg_ratio="-0.27"
percent_change_from_200_day_moving_average="+8.58%"
percent_change_from_50_day_moving_average="+3.09%"
percent_change_from_52_week_high="-18.78%"
percent_change_from_52_week_low="+67.82%"
previous_close="11.59"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="9.29"
revenue="159.91M"
shares_outstanding="128154000"
short_ratio="18.81"
stock_exchange="NMS"
symbol="HALO"
volume="1868315"
weeks_range_52="6.96 - 14.38"
